Investor Relations

TriEye company is launching a capital increase campaign hosted by the Norwegian crowdfunding platform Folkeinvest in order to gain strength and speed in our international expansion.


TriEye has an extensive international patent pending program PCT/EP 2018/073198.

Patent was granted in USA in February 2022 and in Europe in October 2022. Still pending in other countries.